Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Another New Low of the Year Established

To calculate forward P/E you need a number for earnings estimate. Right now I would put the forward P/E at Not Available. That is the problem here. There is no idea if/what/when about future earnings. It will get no new buyers and "longs" will slowly bleed off. That's why the PPS is where it is.

It's lucky to be trading at a multiple of cash, let alone TTM earnings

I agree,and have said so in the past, we really have no PE or even a solid EPS when one excludes one time earnings just as one time expenses are excluded from these calculations...normally so anyway. And as far as ffuture PE is concerned we don't even qualify for that ratio....yet.

Thus once again the concentration by RG for acqusitions and JV's etc. etc. is where we need to focus our time and money for now...that will lead us to ongoing rev's which is what the investors who may buy in will look for...at least those willing for a LT hold.

RG knows where we need to be headed...JMO.

Share
New Message
Please login to post a reply